Geode Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History
Bought
Maintained
Sold
Other funds holding OACC
Geode Capital Management's OACC Position: Q3 2026 in Review
Geode Capital Management held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q3 2026 at 15,243 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #3927.
Geode Capital Management first reported a position in OACC in Q3 2025 and has held it in 5 quarters since. 15 funds tracked by Wall St. Rank hold OACC as of Q3 2026.
- Geode Capital Management held 15,243 shares of Oaktree Acquisition Corp III Life Sciences worth $164K as of Q3 2026.
- Geode Capital Management left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q3 2026.
- Oaktree Acquisition Corp III Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3927 holding.
- Geode Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q3 2025 and has held it in 5 quarters since.
- 15 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.